Tirapazamine
Tirapazamine is a pharmaceutical drug with 18 clinical trials. Currently 2 active trials ongoing. Historical success rate of 81.3%.
Success Metrics
Based on 13 completed trials
Phase Distribution
Phase Distribution
7
Early Stage
7
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
81.3%
13 of 16 finished
18.8%
3 ended early
2
trials recruiting
18
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
A Phase II/III Trial Comparing Transarterial Tirapazamine Embolization (TATE) With cTACE for Intermediate-stage Liver Cancer.
Evaluate the Effect of Tirazamine on Primary Liver Cancer.
TATE Versus TACE in Intermediate Stage HCC
Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer
Clinical Trials (18)
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
A Phase II/III Trial Comparing Transarterial Tirapazamine Embolization (TATE) With cTACE for Intermediate-stage Liver Cancer.
Evaluate the Effect of Tirazamine on Primary Liver Cancer.
TATE Versus TACE in Intermediate Stage HCC
Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer
TRACE: Tirapazamine-Radiation And Cisplatin Evaluation
Tirapazamine, Carboplatin, and Paclitaxel in Treating Patients With Advanced Malignant Solid Tumors
Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer
Tirapazamine Combined With Chemo and RT in Limited-Stage Small Cell Lung Cancer
Cisplatin Plus Vinorelbine With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Tirapazamine, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer
Combination Chemotherapy With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
Tirapazamine Plus Cyclophosphamide in Treating Children With Refractory Solid Tumors
Comparison of Chemotherapy Regimens in Treating Children With Relapsed or Progressive Rhabdomyosarcoma
S0004: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-stage Small Cell Lung Cancer
S9717 Tirapazamine Plus Cisplatin in Treating Patients With Metastatic, Recurrent, or Refractory Cervical Cancer
Tirapazamine Plus Cisplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Primary Peritoneal Cancer
Chemotherapy, Tirapazamine, and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
All 18 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 18